Annual Accounts Payable
$39.19 M
-$13.93 M-26.22%
December 31, 2023
Summary
- As of February 7, 2025, MED annual accounts payable is $39.19 million, with the most recent change of -$13.93 million (-26.22%) on December 31, 2023.
- During the last 3 years, MED annual accounts payable has risen by +$3.10 million (+8.59%).
- MED annual accounts payable is now -44.72% below its all-time high of $70.89 million, reached on December 31, 2021.
Performance
MED Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
N/A
September 30, 2024
Summary
- MED quarterly accounts payable is not available.
Performance
MED Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MED Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.2% | - |
| 3 y3 years | +8.6% | - |
| 5 y5 years | +106.1% | - |
MED Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.7% | at low | ||
| 5 y | 5-year | -44.7% | +73.4% | ||
| alltime | all time | -44.7% | >+9999.0% |
Medifast Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $39.19 M(-26.2%) | $39.19 M(-62.0%) |
| Sep 2023 | - | $103.22 M(-1.9%) |
| Jun 2023 | - | $105.19 M(-7.2%) |
| Mar 2023 | - | $113.30 M(+113.3%) |
| Dec 2022 | $53.12 M(-25.1%) | $53.12 M(-25.1%) |
| Dec 2021 | $70.89 M(+96.4%) | $70.89 M(+96.4%) |
| Dec 2020 | $36.09 M(+59.6%) | $36.09 M(+59.6%) |
| Dec 2019 | $22.61 M(+18.9%) | $22.61 M(-69.6%) |
| Mar 2019 | - | $74.45 M(+291.5%) |
| Dec 2018 | $19.02 M(+37.8%) | $19.02 M(-69.7%) |
| Sep 2018 | - | $62.81 M(+17.5%) |
| Jun 2018 | - | $53.44 M(+40.0%) |
| Mar 2018 | - | $38.19 M(+176.8%) |
| Dec 2017 | $13.80 M(+44.0%) | $13.80 M(-47.4%) |
| Sep 2017 | - | $26.25 M(+4.4%) |
| Jun 2017 | - | $25.14 M(+8.6%) |
| Mar 2017 | - | $23.15 M(+141.6%) |
| Dec 2016 | $9.58 M(-15.0%) | $9.58 M(-60.8%) |
| Sep 2016 | - | $24.42 M(+9.2%) |
| Jun 2016 | - | $22.36 M(-6.1%) |
| Mar 2016 | - | $23.82 M(+111.5%) |
| Dec 2015 | $11.26 M(-7.5%) | $11.26 M(-44.2%) |
| Sep 2015 | - | $20.18 M(-5.1%) |
| Jun 2015 | - | $21.26 M(-16.5%) |
| Mar 2015 | - | $25.47 M(+109.1%) |
| Dec 2014 | $12.18 M(+1.2%) | $12.18 M(-55.0%) |
| Sep 2014 | - | $27.09 M(+7.5%) |
| Jun 2014 | - | $25.21 M(-3.6%) |
| Mar 2014 | - | $26.16 M(+117.4%) |
| Dec 2013 | $12.03 M(-25.9%) | $12.03 M(-60.3%) |
| Sep 2013 | - | $30.34 M(-1.1%) |
| Jun 2013 | - | $30.68 M(-0.3%) |
| Mar 2013 | - | $30.78 M(+89.7%) |
| Dec 2012 | $16.23 M(+28.0%) | $16.23 M(+28.0%) |
| Dec 2011 | $12.68 M | $12.68 M(-39.4%) |
| Jun 2011 | - | $20.93 M(+43.9%) |
| Sep 2010 | - | $14.55 M(+14.9%) |
| Jun 2010 | - | $12.66 M(+19.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $10.62 M(+86.0%) |
| Jun 2009 | - | $5.71 M(+11.3%) |
| Dec 2008 | $5.13 M(+61.3%) | $5.13 M(+11.7%) |
| Sep 2008 | - | $4.59 M(-27.2%) |
| Jun 2008 | - | $6.31 M(+17.2%) |
| Mar 2008 | - | $5.38 M(+69.2%) |
| Dec 2007 | $3.18 M(+43.7%) | $3.18 M(+13.4%) |
| Sep 2007 | - | $2.81 M(-33.0%) |
| Jun 2007 | - | $4.18 M(+15.8%) |
| Mar 2007 | - | $3.62 M(+63.3%) |
| Dec 2006 | $2.21 M(-2.2%) | $2.21 M(-16.8%) |
| Sep 2006 | - | $2.66 M(-23.5%) |
| Jun 2006 | - | $3.48 M(+19.3%) |
| Mar 2006 | - | $2.92 M(+28.9%) |
| Dec 2005 | $2.26 M(+140.7%) | $2.26 M(+8.2%) |
| Sep 2005 | - | $2.09 M(+51.3%) |
| Jun 2005 | - | $1.38 M(+21.7%) |
| Mar 2005 | - | $1.14 M(+20.9%) |
| Dec 2004 | $940.00 K(-45.2%) | $940.00 K(-15.3%) |
| Sep 2004 | - | $1.11 M(-3.1%) |
| Jun 2004 | - | $1.15 M(-23.6%) |
| Mar 2004 | - | $1.50 M(-12.5%) |
| Dec 2003 | $1.71 M(+44.2%) | $1.71 M(-28.6%) |
| Sep 2003 | - | $2.40 M(-6.0%) |
| Jun 2003 | - | $2.55 M(+235.2%) |
| Mar 2003 | - | $762.00 K(-35.9%) |
| Dec 2002 | $1.19 M(+252.8%) | $1.19 M(+12.6%) |
| Sep 2002 | - | $1.06 M(+62.7%) |
| Jun 2002 | - | $649.00 K(+8.7%) |
| Mar 2002 | - | $597.00 K(+77.2%) |
| Dec 2001 | $337.00 K(-3.2%) | $337.00 K(-9.4%) |
| Sep 2001 | - | $372.00 K(+6.0%) |
| Jun 2001 | - | $351.00 K(-14.4%) |
| Mar 2001 | - | $410.00 K(+17.8%) |
| Dec 2000 | $348.00 K(-60.4%) | $348.00 K(-39.1%) |
| Sep 2000 | - | $571.70 K(+10.8%) |
| Jun 2000 | - | $516.20 K(-0.7%) |
| Mar 2000 | - | $520.00 K |
| Dec 1999 | $878.00 K | - |
FAQ
- What is Medifast annual accounts payable?
- What is the all time high annual accounts payable for Medifast?
- What is Medifast annual accounts payable year-on-year change?
- What is the all time high quarterly accounts payable for Medifast?
What is Medifast annual accounts payable?
The current annual accounts payable of MED is $39.19 M
What is the all time high annual accounts payable for Medifast?
Medifast all-time high annual accounts payable is $70.89 M
What is Medifast annual accounts payable year-on-year change?
Over the past year, MED annual accounts payable has changed by -$13.93 M (-26.22%)
What is the all time high quarterly accounts payable for Medifast?
Medifast all-time high quarterly accounts payable is $113.30 M